Indo Borax Q4 FY26: Income up 21% YoY, PAT +42% snapshot

What’s driving attention to Indo Borax & Chemicals

Indo Borax & Chemicals has come into focus after a mix of reported quarterly swings, full-year FY26 numbers, and a fresh board meeting intimation for approval of unaudited results for the quarter ended 30 June, 2026. The stock was last reported trading at ₹400.40, with a separate update noting it was down 2.41% versus the previous close of ₹412.25 as of 07 Aug, 2026 (03:59 PM IST).

For investors tracking smaller chemical manufacturers, the combination of sequential volatility and year-on-year growth in profit is often the key story. The dataset provided also includes a quarterly trend table through March 2026, along with FY26 income and profit figures.

FY26 headline numbers: income and profit

For the full year FY2026–2027 (as stated in the source text), revenue reached ₹230.89 crore and profit touched ₹50.27 crore. Separately, FY26 total income is also stated as ₹230.8866 crore (₹23,088.66 lakh), up 20.97% from FY25 total income of ₹190.8537 crore (₹19,085.37 lakh).

These two presentations align closely in magnitude and point to FY26 as a year of higher income versus FY25. The provided material does not include a full FY26 expense breakdown, but it does include quarter-level totals and growth rates.

Q4 FY26 performance: total income and revenue from operations

For Q4 FY26 (March 2026 quarter in the table), Total Income (Net) is given at ₹67.53 crore (₹6,753.00 lakh). This is described as up 48.90% quarter-on-quarter from ₹45.35 crore in Q3 FY26 (₹4,535.12 lakh), and up 25.37% year-on-year from ₹53.87 crore in Q4 FY25 (₹5,386.65 lakh).

Revenue from Operations for Q4 FY26 is stated at ₹63.0107 crore (₹6,301.07 lakh). This is reported as up 53.59% QoQ from ₹41.0242 crore in Q3 FY26 (₹4,102.42 lakh) and up 25.73% YoY from ₹50.1166 crore in Q4 FY25 (₹5,011.66 lakh).

Net profit for Q4 FY26 is reported at ₹14.5323 crore (₹1,453.23 lakh), up 56.73% QoQ from ₹9.2719 crore in Q3 FY26, and up 41.90% YoY from ₹10.2410 crore in Q4 FY25.

Quarterly trend: income, expenses, margins and EPS

The quarterly table in the source (March 2026 to March 2025) shows how the company’s income and profitability moved across five quarters. It includes income, expenses, EBIT, PAT, margins, and basic EPS.

The table shows that September 2025 carried higher margins (EBIT margin 36.72% and net profit margin 26.48%), while March 2026 delivered the highest income in this set. Expenses also rose sharply in March 2026 compared with December 2025, alongside a strong PAT increase.

Q1 (June 2025) snapshot: revenue and operating profit movement

A separate quarterly snapshot (June 2025 vs March 2026) shows Total Revenue of ₹53.57 crore in June 2025 versus ₹63.01 crore in March 2026, with a QoQ comparison line of 6.89% in the table. It also lists Net Income of ₹10.20 crore for June 2025 and ₹14.53 crore for March 2026, with a QoQ comparison line of -0.36%.

The same source text also states: “The revenue stands at ₹53.57 crore, reflecting a quarter-on-quarter (QoQ) increase of 6.88 per cent from ₹50.12 crore,” and adds that this corresponds to YoY growth of 7.66%. It further states operating profit at ₹3.02 crore, down 22.96% QoQ from ₹3.92 crore, and down 7.08% YoY.

Earlier quarter reference: Q3 FY25 highlights

For Q3 FY25 (quarter-ended December), the source notes Indo Borax & Chemicals reported a 1.1% QoQ decrease in consolidated revenues, and a 10.8% decline YoY. Expenses for that quarter were down 4.0% QoQ and 20.8% YoY.

It also states net profit decreased 1.2% QoQ and increased 10.2% YoY, with EPS at 2.8 for Q3 FY25. These figures add context to the later FY26 pattern of sharp quarter-to-quarter changes.

Board meeting and disclosures: June 2026 unaudited results

The company disclosed a board meeting intimation for consideration and approval of unaudited financial results for the quarter ended 30 June, 2026. The meeting tracker table in the source lists a board meeting dated Aug 9, 2026 (announced on Aug 3, 2026) for “Quarterly Results.”

The material also mentions auditor-related approvals: appointment of M/s. Shah Kapadia & Associates as Internal Auditor for FY26-27 and re-appointment of M/s. V. B. Modi & Associates as Cost Auditor for FY26-27. In addition, it notes the consolidated financial results include the audited results of subsidiary Indoborax Infrastructure Private Limited.

Stock price, valuation datapoint, and differing “CMP” references

One price line states “stock last traded price is 400.40,” and another notes the share price was ₹400.40 and down 2.41% versus the previous closing price of ₹412.25 as of 07 Aug, 2026 (03:59 PM IST). The source also contains a separate reference: “Indo Borax and Chemicals CMP Rs.414.”

The same section that references CMP ₹414 also provides additional datapoints: market capitalisation of ₹1,318 crore and a price-to-earnings multiple of 26.2. These valuation references are presented as part of a Q1 FY27 results season preview.

Q1 FY27 estimates cited in the source (range-based)

The source includes a range-based estimate table labelled “Indo Borax and Chemicals Q1 FY27 Estimates.” It lists revenue estimate of ₹66-76 crore versus Q1 FY26 actual of ₹57 crore (YoY growth shown as +25.4%), and net profit (PAT) estimate of ₹13-16 crore versus Q1 FY26 actual of ₹10 crore (YoY growth shown as +41.9%).

It also states the results date as “July-August 2026 (indicative)” and a “12-Month Target (Uniresearch Estimate)” range of ₹497-550. Separately, the preview text notes the estimates are built using a trailing-growth framework applied to a Q1 FY26 base of ₹57 crore revenue and ₹10 crore net profit, and references a “most recent reported quarter (Q4 FY26)” showing revenue of ₹68 crore and net profit of ₹15 crore as the base for the estimate framework.

Geographic revenue datapoint cited for India

The material includes a country-wise statement: “The greatest contribution came from India, which accounted for 2.15 B INR last year, with 1.75 B INR the year before.” Normalised to ₹ crore, that equals ₹215 crore last year versus ₹175 crore the prior year.

It also lists a sequence for India in the same section: ₹176 crore, ₹225 crore, ₹191 crore, ₹175 crore, and ₹215 crore (each originally shown as 1.76 B, 2.25 B, 1.91 B, 1.75 B, 2.15 B INR).

Key takeaways for investors watching the next result

Across the provided quarterly series, March 2026 shows strong QoQ expansion in total income and PAT, alongside higher expenses and mid-20s margins. The board meeting schedule and intimation for June 2026 unaudited results add a near-term event that can reset market expectations.

The presence of published estimate ranges for Q1 FY27, along with a stated target range of ₹497-550 from Uniresearch, indicates active market positioning around the next print. Investors will typically compare the upcoming June 2026 quarter numbers against the recent volatility seen between December 2025, September 2025, and March 2026.

Conclusion

Indo Borax & Chemicals reported FY26 total income of about ₹230.89 crore and Q4 FY26 total income of ₹67.53 crore, with Q4 PAT at ₹14.53 crore. With the board meeting listed for Aug 9, 2026 to consider quarterly results for the June 2026 quarter, the next set of unaudited numbers will be the key near-term trigger to watch.